Sotac Pharmaceuticals Ltd (SOTA)

NSE
Currency in INR
108.40
-4.45(-3.94%)
Closed·
SOTA Scorecard
Full Analysis
Stock has taken a big hit over the last week
SOTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
107.20108.50
52 wk Range
88.05202.80
Key Statistics
Edit
Bid/Ask
107.30 / 118.40
Prev. Close
112.85
Open
107.2
Day's Range
107.2-108.5
52 wk Range
88.05-202.8
Volume
6K
Average Volume (3m)
5.33K
1-Year Change
-8.14%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SOTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Sotac Pharmaceuticals Company Profile

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin. The company also offers beta and non-beta-lactam tablets; beta and non-beta-lactam capsules; oral liquids; dry syrups; and external preparations, such as nasal sprays, relief sprays, and creams. In addition, it is involved in the research of pharmaceutical molecules used in developing new pharmaceutical formulations; and manufacture of nutraceuticals medicinal and food products. The company also exports its products. Sotac Pharmaceuticals Limited was founded in 2014 and is based in Ahmedabad, India.

Employees
68
Market
India

Compare SOTA to Peers and Sector

Metrics to compare
SOTA
Peers
Sector
Relationship
P/E Ratio
26.9x6.5x−0.5x
PEG Ratio
-0.050.00
Price/Book
2.5x1.1x2.6x
Price / LTM Sales
1.1x0.8x3.0x
Upside (Analyst Target)
-0.0%52.4%
Fair Value Upside
Unlock16.2%8.7%Unlock

Earnings

Latest Release
Oct 29, 2024
EPS / Forecast
0.48 / --
Revenue / Forecast
273.46M / --
EPS Revisions
Last 90 days

SOTA Income Statement

FAQ

What Is the Sotac Pharmaceuticals (SOTA) Stock Price Today?

The Sotac Pharmaceuticals stock price today is 108.40.

What Stock Exchange Does Sotac Pharmaceuticals Trade On?

Sotac Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Sotac Pharmaceuticals?

The stock symbol for Sotac Pharmaceuticals is "SOTA."

What Is the Sotac Pharmaceuticals Market Cap?

As of today, Sotac Pharmaceuticals market cap is 1.20B.

What Is Sotac Pharmaceuticals's Earnings Per Share (TTM)?

The Sotac Pharmaceuticals EPS (TTM) is 4.04.

From a Technical Analysis Perspective, Is SOTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sotac Pharmaceuticals Stock Split?

Sotac Pharmaceuticals has split 0 times.

How Many Employees Does Sotac Pharmaceuticals Have?

Sotac Pharmaceuticals has 68 employees.

What is the current trading status of Sotac Pharmaceuticals (SOTA)?

As of 21 Jun 2025, Sotac Pharmaceuticals (SOTA) is trading at a price of 108.40, with a previous close of 112.85. The stock has fluctuated within a day range of 107.20 to 108.50, while its 52-week range spans from 88.05 to 202.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.